Skip to content

Exercise therapy on osteoporosis

Effects of Aerobic and Strengthening Exercises on Balance, Muscle Strength and Bone Density among the Post Menopausal Women with Osteopenia and Osteoporosis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201008153217N2
Enrollment
90
Registered
2010-09-14
Start date
2009-11-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post menopausal osteoporosis. Post menopausal osteoporosis without fracture

Interventions

Intervention 1: Drug therapy, including alendronate, calcium and vitamin D in control groups. Intervention 2: Drug therapy, including alendronate, calcium and vitamin D as well as Aerobic exercises in
warm up for 10 minutes,walking on treadmill with 60-80% of maximum heart rate and stationary cycling for 30 minutes and finally cooling down for 5 minutes following by relaxation and stretching exerci
against resistence are performing.Each interventional group is including 10-15 patients and these exercises are conducted for 6 months with one month resting phase.
Treatment - Drugs
Rehabilitation
Drug therapy, including alendronate, calcium and vitamin D as well as Aerobic exercises including three steps
Drug therapy, including alendronate, calcium and vitamin D as well as Strengthening exercises for trunk extensors,hip abductors and knee extensors or quadriceps muscles initially Isometric and then Is
Drug therapy, including alendronate, calcium and vitamin D in control groups

Sponsors

Research Chancellor of Tabriz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
47 Years to 75 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria:post menopausal women with severe osteopenia and osteoporosis (T-score<-2.5). Exclusion Criteria : presence of severe cardiovascular disease, severe joint degenerative diseases or severe musculoskeletal disorders and performing physical activities other than our prescribed exercise programs.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Bone Mineral Density (BMD). Timepoint: before intervention and 6 months after intervention (immidiately after termination of treatment). Method of measurement: using Dual Energy X-ray Absorbtiometry (DEXA) with measurment of T-score.;Time up & go (TUG). Timepoint: before intervention and 6 months after intervention (immidiately after termination of treatment). Method of measurement: using chronometer this six meter distance is measured by seconds.;Fall risk. Timepoint: before intervention and 6 months after intervention (immidiately after termination of treatment). Method of measurement: using Biodex balance training is measured and because it is a relative value,it has not special unit.;Postural Stability. Timepoint: before intervention and 6 months after intervention (immidiately after termination of treatment). Method of measurement: using Biodex balance training is measured and because it is a relative value,it has not special unit.;Muscle Strength. Timepoint: before intervention and 6 months after intervention (immidiately after termination of treatment). Method of measurement: It is evaluated via manual muscle testing(MMT) in physical examination.This relative indicator is measured between 1/5 to 5/5.

Secondary

MeasureTime frame
Quality of life. Timepoint: before intervention and 6 months after intervention (Immediately after treatment). Method of measurement: This variable is measured using SF36 Questionnaire with scoring between 0 to 100.;Body Mass Index (BMI). Timepoint: before intervention and 6 months after intervention (Immediately after treatment). Method of measurement: BMI is measured by body composition test instrumentation and its unit is Kg/m2.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactJalil Toofan

Tabriz University of Medical Sciences

jtoofan_1974@yahoo.com+98 41 1337 3967

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026